Enanta Pharmaceuticals
ENTA
ENTA
132 hedge funds and large institutions have $338M invested in Enanta Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 33 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 131 → 132 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less capital invested
Capital invested by funds: $416M → $338M (-$78M)
Holders
132
Holding in Top 10
1
Calls
$496K
Puts
$215K
Top Buyers
| 1 | +$7.28M | |
| 2 | +$2.84M | |
| 3 | +$2.27M | |
| 4 |
KAM
Krensavage Asset Management
New York
|
+$1.34M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$1.34M |
Top Sellers
| 1 | -$6.92M | |
| 2 | -$2.35M | |
| 3 | -$1.58M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.3M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.11M |
